fda compounding semaglutide enforcement news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Semaglutide Shortage Ends: Compounded Versions

The countdown timer The current promotional landing page displays a "Summer Sale" countdown clock (roughly fifteen minutes remaining at the time this page was reviewed) alongside "LAST DAY TO GRAB THIS!" messaging and a 70% discount claim against a stated $99.99 retail price

Myeloperoxidase: friend and foe

doi: 10.1152/ajpheart.01080.2010 6 LeroyerASIsobeHLesecheGCastierYWassefMMallatZet al

This is the first step toward developing that knowledge, which will require large-scale, carefully controlled clinical trials. Huda Akil, Ph.D., the co-director and research professor at the Molecular and Behavioral Neuroscience Institute (MBNI) at the University of Michigan, tells GEN that severe, untreatable depression is remarkably difficult to unpack biologically with multiple paths to becoming depressed (genetic, development, metabolic, social). Because of this complexity, one treatment will not work for everyone. In addition to finding that patients with MDD have less LAC in their blood, the researchers were able to identify subtypes of patient populations based on their LAC levels

HPLC and MS/MS verified per batch with third-party COA available